Texas News Headlines

Soft Tissue Sarcoma Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma Holdings

(Albany, New York) – November 10, 2026: As per DelveInsight’s assessment, globally, Soft Tissue Sarcoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Soft Tissue Sarcoma treatment therapies,

Respiratory Syncytial Virus Market Anticipated to Witness Remarkable Growth by 2034, Says Latest Industry Analysis | GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharma

The Key Respiratory Syncytial Virus Companies in the market include – GSK, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharmaceuticals, ADMA Biologics, Enanta Pharmaceuticals, Merck Sharp & Dohme, Janssen

Age-related Macular Degeneration Clinical Trial Pipeline Expands as 90+ Companies Race to Redefine AMD Treatment Landscape | DelveInsight

The Age-related Macular Degeneration clinical trial analysis report delivers important insights into ongoing research on 100+ pipeline drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) November 10, 2026

Dynamic Industry Brings Mechanical Solar Panel Recycling to TechCrunch Disrupt as U.S. Waste Challenge Grows

NAMWON, South Korea – November 10, 2026 – Dynamic Industry presented its mechanical solar panel recycling technology at TechCrunch Disrupt 2026 in San Francisco, addressing a growing challenge for the

Chronic Myeloid Leukemia Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Chronic Myeloid Leukemia market analysis report delivers important insights into ongoing research on pipeline Chronic Myeloid Leukemia drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November

Brain Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Brain Cancer market analysis report delivers important insights into ongoing research on pipeline Brain Cancer drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November 10, 2026,

Max Elofson Outlines Vision for Future Technology, Electric Mobility, and Design Through KMON and YR2M

Max Elofson, Founder of KMON and YR2M™ Drink Tech. Entrepreneur’s ventures explore gesture-controlled EVs, artificial intelligence, aerial mobility, and innovative beverage design. Los Angeles, CA – November 10, 2026 – Entrepreneur

Primary Progressive Multiple Sclerosis Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Primary Progressive Multiple Sclerosis market analysis report delivers important insights into ongoing research on pipeline Primary Progressive Multiple Sclerosis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)

IgA Nephropathy Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The IgA Nephropathy market analysis report delivers important insights into ongoing research on pipeline IgA Nephropathy drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November 10, 2026,

Dry Eye Disease Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Dry Eye Disease market analysis report delivers important insights into ongoing research on pipeline Dry Eye Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On November

Soft Tissue Sarcoma Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | OncoTherapy Science, Foghorn Therapeutics, C4 Therapeutics, Lyvgen Biopharma Holdings

Loading, Please Wait!